Clinical trial
A Randomized Trial of the Effect of Low-Molecular-Weight Heparin Versus Warfarin Sodium on the Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (Main LITE Study)
NCT00203580 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial of the Effect of Low-Molecular-Weight Heparin Versus Warfarin Sodium on the Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (Main LITE Study)
- Lead sponsor
- University of Calgary
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 1994
- Completion date
- March 31, 2002
- Enrollment
- 910
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.